On February 2, 2026, the FDA stopped using the Quality System Inspection Technique (QSIT) for device inspections and began utilizing the inspection process described in the updated Inspection of ...

Environmental monitoring is a cornerstone of pharmaceutical manufacturing, ensuring product quality, patient safety and regulatory compliance across both sterile and non-sterile operations. Yet many ...

The Bureau of Safety and Environmental Enforcement (BSEE) this week announced the implementation of a new Risk-Based Inspection Program that employs a systematic framework to identify facilities and ...

On February 2, 2026, the U.S. Food and Drug Administration (FDA) published its anticipated compliance program manual, Inspection of Medical Device Manufacturers (CP 7382.850), to explain how the ...

After formally adopting API Standard 653 for its tank inspection and repair program, Colonial Pipeline Co, Atlanta, Ga., has developed procedures based on risk-management principles to level the load ...

State and federal officials will now have unified federal standards guiding produce inspections under new guidelines being ...

On February 2, 2026, the U.S. Food and Drug Administration’s long-awaited harmonization of the medical device good manufacturing practice regulations with the international ISO 13485 standard, Medical ...

At-a-Glance: Offshore platform integrity management is a risk-based, lifecycle program that preserves containment and structural fitness by integrating RBI/FFS assessments, targeted inspections/NDT, ...